Gujarat Kidney Acquires 51% Stake in Dubai's Blue Tree Clinics for ₹19.84 Crore

HEALTHCAREBIOTECH
Whalesbook Corporate News Logo
AuthorRiya Kapoor|Published at:
Gujarat Kidney Acquires 51% Stake in Dubai's Blue Tree Clinics for ₹19.84 Crore

Gujarat Kidney and Super Speciality Ltd is acquiring a 51% stake in Dubai-based Blue Tree Clinics LLC for ₹19.84 crore. This move expands its business into a new geography and adds services like plastic surgery and dentistry.

Gujarat Kidney Acquires 51% Stake in Dubai's Blue Tree Clinics for ₹19.84 Crore

Gujarat Kidney And Superspeciality Limited will acquire a 51% stake in Dubai-based Blue Tree Clinics LLC for ₹19.84 crore. The acquisition aims to expand the company's operations into the United Arab Emirates.

Reader Takeaway: International expansion and diversification; IPO fund reallocation requires shareholder approval.

What just happened

Gujarat Kidney and Super Speciality Ltd announced a Share Purchase Agreement to acquire 51% of Blue Tree Clinics LLC, a polyclinic in Dubai, UAE. The cash deal is valued at ₹19.84 crore and is expected to be completed within 50 days.

Why this matters

This acquisition represents a significant step for Gujarat Kidney in expanding its geographical footprint beyond India. It will also introduce new service lines such as plastic surgery, laser cosmetic treatments, general dentistry, and chiropractic services, diversifying its revenue streams.

The backstory

Gujarat Kidney and Super Speciality Ltd is a healthcare provider. This is its first major international acquisition, aiming to leverage the growing healthcare market in the UAE.

What changes now

The company will integrate Blue Tree Clinics' operations, aiming to achieve synergies and growth in the new market. Shareholders will vote on a 'Variation in Objects of IPO' via postal ballot, potentially reallocating funds raised during its initial public offering.

Risks to watch

Integration challenges of the new Dubai entity and the outcome of the postal ballot on IPO fund reallocation are key factors to monitor. The company's ability to manage international operations and regulations will be crucial.

Peer comparison

Several Indian healthcare companies have expanded internationally, but this direct acquisition of a polyclinic in Dubai by Gujarat Kidney marks a specific strategic move into a competitive market.

Context metrics

Blue Tree Clinics LLC reported gross revenue of AED 10,538,978 in FY 2025 and AED 9,068,150 in FY 2024. Its net profit for FY 2025 was AED 3,138,809. FY 2024 net profit was not available.

What to track next

Investors should watch for updates on the completion of the acquisition, the integration progress of Blue Tree Clinics, and the results of the postal ballot concerning the variation in IPO objects.

Disclaimer:This article is published for informational purposes only. While reasonable efforts are made to ensure accuracy, completeness, and timeliness, readers are encouraged to independently verify information before making any decisions based on the content. The views and information presented are subject to editorial review and may be updated without notice.